• FH1 (Catalog No. B3700): iHep Maturation

  2026-08-19

  A scenario-based guide to using FH1 (Catalog No. B3700), SKU B3700, for iPS cell differentiation to hepatocytes, hepatocyte-like cell culture, and functional assay interpretation. It connects documented albumin, CYP3A4, AFP, formulation, and handling data with practical controls for more defensible laboratory decisions.

• TBXA2R–ERM Signaling Drives TNBC Metastasis

  2026-08-19

  Leguay et al. identify TBXA2R as an upstream GPCR that activates ezrin, radixin, and moesin through Gαq/11, Gα12/13, Rho GTPases, and the kinases SLK and LOK. The resulting TBXA2R–ERM axis promotes triple-negative breast cancer motility, invasion, and metastatic colonization, providing a mechanistic framework for studying GPCR-controlled cytoskeletal remodeling.

• Genotyping Kit for Target Alleles: Workflow Guide

  2026-08-18

  Accelerate allele screening with direct PCR templates from insects, tissues, fish samples, and cultured cells. This practical guide connects single-tube DNA preparation with the E-cadherin genotyping needs raised by a recent colitis study while emphasizing assay validation and troubleshooting.

• Gemcitabine: Reliable DNA Damage Assays

  2026-08-18

  This scenario-driven guide explains how Gemcitabine, SKU A8437, can support reproducible viability, proliferation, apoptosis, and DNA damage response workflows. It connects practical formulation and handling decisions with mechanistic evidence relevant to osteosarcoma and cholangiocarcinoma research.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-17

  Oh et al. developed a scalable human iPSC-derived sensory neuron system that supports experimentally defined HSV-1 latency and stimulus-induced reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based readouts, creating a useful platform for studying human neuron-intrinsic mechanisms that are difficult to resolve in animal models.

• BIRB 796 (Doramapimod): p38α MAPK Guide

  2026-08-17

  BIRB 796, also called Doramapimod, is a highly selective allosteric p38α MAPK inhibitor with a reported binding Kd of 0.1 nM. It is a research tool for inflammation research, cytokine production inhibition, apoptosis studies, and cancer-biology experiments, but preclinical activity does not establish clinical efficacy.

• Alda 1: From Aldehyde Control to Cardiac Repair

  2026-08-16

  Alda 1 is an ALDH2 activator that connects aldehyde detoxification with cardiomyocyte cell-cycle biology. This evidence-focused guide explains how to design assays that distinguish cytoprotection, cardiac regeneration, and pressure-overload responses.

• Western Secondary Antibody Dilution Buffer Guide

  2026-08-15

  Improve protein detection Western blot workflows with a stabilized reagent designed to reduce background and support controlled secondary-antibody reuse. The workflow below applies these advantages to macrophage inflammation studies, including NHE1, Olfr2, calcium-dependent ROS, and NLRP3 research.

• Neurotensin: A Strategic Tool for GPCR Translation

  2026-08-15

  Neurotensin offers translational researchers a controlled way to connect NTR1 activation with receptor trafficking and miR-133α regulation. This thought-leadership article outlines mechanistic rationale, protocol design, analytical controls, competitive positioning, and the limits of extending evidence from gastrointestinal models toward broader translational programs.

• Meropenem: Bench Workflows for Resistance Research

  2026-08-14

  Meropenem supports reproducible susceptibility testing, time-kill experiments, Gram-negative infection models, and translational studies of carbapenem resistance. This guide connects its PBP-directed mechanism with practical preparation, exposure design, nanoparticle comparisons, and troubleshooting strategies.

• Neuromedin S (rat): GPCR Assay Guide

  2026-08-14

  Neuromedin S (rat), SKU B5466, provides a defined peptide ligand for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. This guide covers preparation, assay setup, and quality control; the reagent is for research use only and is not validated for diagnostic, therapeutic, or medical applications.

• Native Protein Gel Electrophoresis with K4142

  2026-08-13

  Use K4142 to separate acidic proteins in a native state when preserving conformation, charge, and enzymatic activity matters more than denatured molecular-weight estimates. This practical workflow connects gel preparation, activity-focused analysis, and orthogonal cancer-biology assays while highlighting the limits of native PAGE interpretation.

• PR-619: Reversible DUB Inhibitor for Cell Assays

  2026-08-13

  PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for measuring ubiquitin accumulation without directly blocking proteasomal catalytic activity. This guide translates its solubility profile and broad DUB activity into practical workflows for ubiquitination pathway research, autophagy activation assays, cancer biology research, and exploratory neurodegenerative disease models.

• Caffeine: Applied Workflows for Cancer and Metabolism

  2026-08-12

  Caffeine enables practical, dose-resolved experiments spanning cancer cell line inhibition and energy metabolism modulation. This guide combines solution handling, assay design, combination testing, and a careful bridge to ALDH2-focused ischemia research.

• gamma-Glu-Cys (γ-Glu-Cys): Practical Lab Guide

  2026-08-12

  This guide explains how to use gamma-Glu-Cys (γ-Glu-Cys) as a defined intermediate and substrate in glutathione metabolism research, including glutathione synthetase enzyme assay development and related plant workflows. It supports controlled research use only; it should not be treated as a diagnostic or medical reagent, and freshly prepared solutions should be used promptly rather than stored long term.

446 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page